1393907-12-4

Basic information

• Product Name: 8-methoxy-9-[2-(4-phenylpiperazino)ethoxy]-(13aS)-1,2,3,13a-tetrahydro-5H-pyrrolo[2,1-c][1,4]naphthodiazepin-5-one
• Synonyms: 8-methoxy-9-[2-(4-phenylpiperazino)ethoxy]-(13aS)-1,2,3,13a-tetrahydro-5H-pyrrolo[2,1-c][1,4]naphthodiazepin-5-one
• CAS NO: 1393907-12-4
• Molecular Weight: 484.598
• Mol File: 1393907-12-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 8-methoxy-9-[2-(4-phenylpiperazino)ethoxy]-(13aS)-1,2,3,13a-tetrahydro-5H-pyrrolo[2,1-c][1,4]naphthodiazepin-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: 8-methoxy-9-[2-(4-phenylpiperazino)ethoxy]-(13aS)-1,2,3,13a-tetrahydro-5H-pyrrolo[2,1-c][1,4]naphthodiazepin-5-one(1393907-12-4)
• EPA Substance Registry System: 8-methoxy-9-[2-(4-phenylpiperazino)ethoxy]-(13aS)-1,2,3,13a-tetrahydro-5H-pyrrolo[2,1-c][1,4]naphthodiazepin-5-one(1393907-12-4)

Safety Data

• Hazardous Substances Data: 1393907-12-4(Hazardous Substances Data)

Upstream product

• 43041-12-9 methyl (2R)-pyrrolidine-2-carboxylate 
• 1393910-27-4 C₃₃H₄₄N₄O₃S₂ 
• 1393910-26-3 C₃₃H₄₂N₄O₅S₂ 
• 1393909-80-2 [6-(2-chloroethoxy)-7-methoxy-3-nitro-2-naphthyl](2S)-2-[di(ethylsulfanyl)methyl]tetrahydro-1H-1-pyrrolyl methanone 
• 1393910-19-4 methyl (2S)-1-[6-(2-chloroethoxy)-7-methoxy-3-nitro-2-naphthyl]carbonyltetrahydro-1H-2-pyrrolecarboxylate 
• 1393909-62-0 methyl (25S)-1-[6-(2-chloroethoxy)-7-methoxy-3-nitro-2-naphthyl]carbonyltetrahydro-1H-2-pyrrolecarboxylate 
• 1393909-44-8 6-(2-chloroethoxy)-7-methoxy-3-nitro-2-naphthoic acid 
• 348618-24-6 4-(2-chloroethoxy)-5-methoxyphthalaldehyde 
• 348618-23-5 [4-(2-chloroethoxy)-2-(hydroxymethyl)-5-methoxyphenyl]methanol 
• 348618-22-4 2-[(acetyloxy)methyl]-4-(2-chloroethoxy)-5-methoxybenzyl acetate 
• 348618-21-3 1-(2-chloroethoxy)-4,5-bis(chloromethyl)-2-methoxybenzene 
• 53815-60-4 1-(2-chloroethoxy)-2-methoxybenzene 
• 90-05-1 2-methoxy-phenol 

Relevant articles and documents

Pyrrolo[2,1-c][1,4]naphthodiazepine Linked Piperazine Compounds and a Process for the Preparation Thereof

The present invention provides a compound of general formula A, useful as potential antitumour agents against five human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]naphthodiazepine linked substituted piperazine conjugates attached through different alkane spacers of general formula A. (Formula I) General formula A. Where R=R′=(Formula II). n=1-9 and R″=methyl, ethyl, acetyl, benzyl, piperinoyl, 4-fluorophenyl, 4-chlorophenyl, 4-methoxyphenyl, pyridyl, pyrimidyl